Oruka Therapeutics Inc.
ORKA | NASDAQ
$95.52
-$1.35 (-1.39%)
Nov 2, 2026, 11:38 AM ET · Market open
Market Data
Market Cap $6.32B
Enterprise Value $5.54B
Beta -0.39
Average Volume 1.04M
Shares Outstanding (Diluted) 62.87M
Shares Change YoY 48.87%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US6876041087
Price Performance
Price Change 1M 13.0%
Price Change 3M 0.8%
Price Change 6M 43.7%
Price Change YTD 215.1%
Price Change 1Y 264.7%
Price Change 3Y 318.9%
Price Change 5Y 201.5%
1M CAGR (ann.) 2.0%
1Y CAGR (ann.) 250.8%
5Y CAGR (ann.) 41.3%
All-Time CAGR -9.2%
Valuation
PE Ratio -39.22
Forward PE N/A
PEG Ratio -0.72
Forward PEG -4.32
PS Ratio N/A
Forward PS N/A
PB Ratio 5.75
P/FCF Ratio -63.41
P/Adj. FCF Ratio -57.62
P/OCF Ratio -60.17
EV/Sales N/A
EV/EBIT -39.09
EV/EBITDA -39.13
EV/FCF -54.79
Earnings Yield -2.5%
FCF Yield -1.6%
Adj. FCF Yield -1.7%
Financial Health
Net Cash $872.9M
Total Debt $2.55M
Cash & Short-Term Investments $873.56M
Total Assets $1.14B
Current Ratio 38.51
Quick Ratio 38.51
Debt / Equity Ratio 0.00
Debt / EBITDA -0.02
Debt / FCF -0.03
OCF / Debt -39.64
Interest Coverage 0.00
Altman Z-Score 155.06
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -10.1%
Returns
Return on Assets -11.7%
Return on Equity -20.8%
Return on Invested Capital -13.9%
Return on Capital Employed -13.9%
Return on Tangible Assets -11.7%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 16.4%
EPS CAGR 5Y 39.8%
EPS CAGR 10Y 41.9%
FCF CAGR 3Y -73.1%
FCF CAGR 5Y -60.5%
FCF CAGR 10Y -25.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y -21.3%
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.60
EPS Growth Est (next Q) 9.0%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $137.50
Price Target Upside 41.9%
Cash Flow
Operating Cash Flow $-100.92M
Free Cash Flow $-101.15M
Adj. Free Cash Flow $-111.32M
FCF Per Share -$1.61
OCF Per Share -$1.61
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-114K
Operating Income $-155.08M
EBITDA $-141.65M
Net Income $-132.89M
EPS (Diluted) -$2.47
Revenue / Employee N/A
Profit / Employee $-1.95M
Employees 68
Add to Watchlist
Select watchlists to add or remove ORKA